Terms: = Breast cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Clinical Outcome
2 results:
1. Upregulated expression of ddx5 predicts recurrence and poor prognosis in breast cancer.
Li K; Zhao G; Yuan H; Zhang J; Li Q; Gong D; Lin P
Pathol Res Pract; 2022 Jan; 229():153736. PubMed ID: 34923193
[TBL] [Abstract] [Full Text] [Related]
2. Endogenous interaction profiling identifies ddx5 as an oncogenic coactivator of transcription factor Fra-1.
He H; Song D; Sinha I; Hessling B; Li X; Haldosen LA; Zhao C
Oncogene; 2019 Jul; 38(28):5725-5738. PubMed ID: 31015574
[TBL] [Abstract] [Full Text] [Related]
